These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism. Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819 [TBL] [Abstract][Full Text] [Related]
43. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease. Wan Nazaimoon WM; Khalid BA Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636 [TBL] [Abstract][Full Text] [Related]
44. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. Bayer MF; Kriss JP; McDougall IR J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528 [TBL] [Abstract][Full Text] [Related]
45. Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects. Kasagi K; Takeuchi R; Misaki T; Kousaka T; Miyamoto S; Iida Y; Konishi J J Endocrinol Invest; 1997 Apr; 20(4):183-8. PubMed ID: 9211123 [TBL] [Abstract][Full Text] [Related]
46. Irisin levels increase after treatment in patients with newly diagnosed Hashimoto thyroiditis. Uc ZA; Gorar S; Mizrak S; Gullu S J Endocrinol Invest; 2019 Feb; 42(2):175-181. PubMed ID: 29777516 [TBL] [Abstract][Full Text] [Related]
47. The association between irisin and muscle metabolism in different thyroid disorders. Zybek-Kocik A; Sawicka-Gutaj N; Szczepanek-Parulska E; Andrusiewicz M; Waligórska-Stachura J; Białas P; Krauze T; Guzik P; Skrobisz J; Ruchała M Clin Endocrinol (Oxf); 2018 Mar; 88(3):460-467. PubMed ID: 29197093 [TBL] [Abstract][Full Text] [Related]
48. Central irisin administration suppresses thyroid hormone production but increases energy consumption in rats. Tekin S; Erden Y; Ozyalin F; Onalan EE; Cigremis Y; Colak C; Tekedereli I; Sandal S Neurosci Lett; 2018 May; 674():136-141. PubMed ID: 29574218 [TBL] [Abstract][Full Text] [Related]
49. Free triiodothyronine/free thyroxine ratio rather than thyrotropin is more associated with metabolic parameters in healthy euthyroid adult subjects. Park SY; Park SE; Jung SW; Jin HS; Park IB; Ahn SV; Lee S Clin Endocrinol (Oxf); 2017 Jul; 87(1):87-96. PubMed ID: 28374508 [TBL] [Abstract][Full Text] [Related]
50. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617 [TBL] [Abstract][Full Text] [Related]
51. Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans. Vamvini MT; Aronis KN; Panagiotou G; Huh JY; Chamberland JP; Brinkoetter MT; Petrou M; Christophi CA; Kales SN; Christiani DC; Mantzoros CS Eur J Endocrinol; 2013 Dec; 169(6):829-34. PubMed ID: 24062354 [TBL] [Abstract][Full Text] [Related]
52. Both hypothyroidism and hyperthyroidism increase plasma irisin levels in rats. Atici E; Mogulkoc R; Baltaci AK; Menevse E Horm Mol Biol Clin Investig; 2017 Nov; 33(3):. PubMed ID: 29182513 [TBL] [Abstract][Full Text] [Related]
53. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease. Kasagi K; Tamai H; Morita T; Hidaka A; Hatabu H; Misaki T; Iida Y; Ishihara T; Ikekubo K; Kuma K J Clin Endocrinol Metab; 1989 Jun; 68(6):1189-94. PubMed ID: 2566620 [TBL] [Abstract][Full Text] [Related]
55. IGF1 deficiency in newly diagnosed Graves' disease patients. Martin S; Sirbu A; Betivoiu M; Florea S; Barbu C; Fica S Hormones (Athens); 2015; 14(4):651-9. PubMed ID: 26188228 [TBL] [Abstract][Full Text] [Related]
56. Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factors. Stratigou T; Dalamaga M; Antonakos G; Marinou I; Vogiatzakis E; Christodoulatos GS; Karampela I; Papavassiliou AG Endocrine; 2018 Jul; 61(1):83-93. PubMed ID: 29455364 [TBL] [Abstract][Full Text] [Related]
57. Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves' Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients. Araruna LVM; de Oliveira DC; Pereira MC; Moura Neto A; Tambascia MA; Zantut-Wittmann DE Front Endocrinol (Lausanne); 2021; 12():780397. PubMed ID: 35069439 [TBL] [Abstract][Full Text] [Related]
58. Relationships between adiponectin, sex hormone binding globulin and insulin resistance in hyperthyroid Graves' disease women. Siemińska L; Foltyn W; Głogowska-Szeląg J; Kajdaniuk D; Marek B; Nowak M; Walczak K; Kos-Kudła B Endokrynol Pol; 2013; 64(1):26-9. PubMed ID: 23450444 [TBL] [Abstract][Full Text] [Related]
60. [Thyroid hormone changes in women with pre-eclampsia and its relationship with the presence of pre-eclampsia]. Zhou J; Du J; Ma B; Liu X; Qiu H; Li J; Wang X Zhonghua Fu Chan Ke Za Zhi; 2014 Feb; 49(2):109-13. PubMed ID: 24739642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]